N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide

● In Stock

Catalogue No.:VE0024678
CAS No.:N/A
Mol. Formula:C14H21N3O
Mol. Weight:247.34 g/mol

Additional information on N-((3R | 4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide

Parent drug

Tofacitinib

IUPAC Name

N-((3R, 4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide

Pharmacopoeial Synonyms

N/A

Other Synonyms

M-1749 Nitrosamine Impurity

Smiles

C[C@H]1[C@@H](N(N=O)C)CN(CC2=CC=CC=C2)CC1

InChI

InChI=1S/C14H21N3O/c1-12-8-9-17(11-14(12)16(2)15-18)10-13-6-4-3-5-7-13/h3-7, 12, 14H, 8-11H2, 1-2H3/t12-, 14+/m1/s1

Description

N-((3R | 4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide is an N-nitroso derivative of the secondary amine present in Tofacitinib | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Tofacitinib production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url